Author:
Popescu Codruța Alina, ,Mihu Carina, ,Cenariu Diana, ,Vesa Ştefan, ,Baican Adrian, ,Melincovici Carmen Stanca, ,Drulă Rareş, ,Tigu Adrian Bogdan, ,Buzoianu Anca Dana,
Publisher
S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L
Reference30 articles.
1. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review;Armstrong AW, Read C;JAMA,2020
2. Association of Atherosclerosis Prevalence with Age, Race, and Traditional Risk Factors in Patients with Psoriasis;Arnold KA, Treister AD, Lio PA, Alenghat FJ;JAMA Dermatol,2019
3. Blood MicroRNA Expressions in Patients with Mild to Moderate Psoriasis and the Relationship between MicroRNAs and Psoriasis Activity;Alatas ET, Kara M, Dogan G, Akın Belli A;An Bras Dermatol,2020
4. Up-Regulation of MicroRNA-210 Induces Immune Dysfunction via Targeting FOXP3 in CD4+ T Cells of Psoriasis Vulgaris;Zhao M, Wang L, Liang G, Zhang P, Deng X, Tang Q;Clinical Immunology,2014
5. Regulation of Pro-Inflammatory Cytokines TNFα and IL24 by MicroRNA-203 in Primary Keratinocytes;Primo MN, Bak RO, Schibler B, Mikkelsen JG;Cytokine,2012